RxDoctor Payments Data

Robert Moldwin

Urogynecology and Reconstructive Pelvic Surgery · New Hyde Park, NYNPI 1275503021

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $33,410 of the $34,815 with a category attached, or 96.0%. 7 manufacturers reported payments, led by AbbVie at 53.4% of the total. Reporting peaked in 2022 at $14,208 and has fallen 96.8% since, to $461 in 2025. Among urogynecology and reconstructive pelvic surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$34,815in general payments, 2019–2025

Across 29 payments — averaging $1200.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$19K
  • Ironwood Pharmaceuticals, Inc$13K
  • Shionogi Inc$2K
  • Medtronic$391
  • Axonics, Inc.$145
  • Laborie Medical Technologies Corp.$121
  • plus $42 from 1 others
$100,485in research payments, 2019–2025

Across 35 payments — averaging $2871.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$50K
  • Ironwood Pharmaceuticals, Inc$39K
  • Ipsen Innovation$11K

What the payments were for

  • Consulting fees$33,41096%
  • Travel & lodging$3661%
  • Food & beverage$1,0393%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)17$18,576
Ironwood Pharmaceuticals, Inc5$13,439
Shionogi Inc1$2,100
Medtronic(2 entities)3$391
Axonics, Inc.1$145
Laborie Medical Technologies Corp.1$121
GRT US Holding, Inc.1$42

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$34,815 in reported general payments places this provider in the 95th percentile of 90 urogynecology and reconstructive pelvic surgery providers in New York.

See all urogynecology and reconstructive pelvic surgery providers in New York

Medicare billing

Part B allowed, 2024
$195,999
Medicare patients
354
Services billed
2,204

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron51$34,123
GemtesaVibegron35$26,516
PremarinEstrogens, Conjugated14$8,666
Estradiol34$3,163
Silodosin17$2,571
Methenamine Hippurate26$2,492
Dutasteride33$1,642
Tamsulosin Hcl78$1,403
Alfuzosin Hcl ErAlfuzosin Hcl69$1,253
NitrofurantoinNitrofurantoin Macrocrystal27$1,169
Terazosin Hcl35$1,143
Finasteride46$956
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst28$641
Baclofen21$617
Nortriptyline Hcl18$457

Paid to pharmacies, not to this prescriber.

Other urogynecology and reconstructive pelvic surgery in New Hyde Park

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →